Literature DB >> 9506546

Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.

C R Jack1, R C Petersen, Y C Xu, P C O'Brien, S C Waring, E G Tangalos, G E Smith, R J Ivnik, S N Thibodeau, E Kokmen.   

Abstract

A variety of anatomic and functional neuroimaging findings are associated with Alzheimer's disease (AD). One of the strongest imaging associations identified is between AD and hippocampal atrophy. The epsilon4 allele of the apolipoprotein E (ApoE) gene increases the risk of developing AD and lowers the mean age of onset of the disease. The purpose of this study was to assess the association between hippocampal volume and ApoE polymorphisms in elderly control subjects and in patients with probable AD. We performed magnetic resonance imaging-based volume measurements of the hippocampus in 125 cognitively normal elderly controls and 62 patients with probable AD. ApoE genotyping was performed by using standard methods. Hippocampal volumes were significantly smaller in AD cases than in control subjects. Hippocampal volumes did not differ significantly within either clinical group on the basis of ApoE genotype. Both the epsilon4 allele of ApoE and hippocampal atrophy were significantly but independently associated with AD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506546      PMCID: PMC2752747          DOI: 10.1002/ana.410430307

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  63 in total

Review 1.  MRI-based hippocampal volume measurements in epilepsy.

Authors:  C R Jack
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

2.  The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation.

Authors:  M J de Leon; J Golomb; A E George; A Convit; C Y Tarshish; T McRae; S De Santi; G Smith; S H Ferris; M Noz
Journal:  AJNR Am J Neuroradiol       Date:  1993 Jul-Aug       Impact factor: 3.825

3.  The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease.

Authors:  R Mayeux; Y Stern; R Ottman; T K Tatemichi; M X Tang; G Maestre; C Ngai; B Tycko; H Ginsberg
Journal:  Ann Neurol       Date:  1993-11       Impact factor: 10.422

4.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

5.  Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation.

Authors:  A Convit; M J de Leon; J Golomb; A E George; C Y Tarshish; M Bobinski; W Tsui; S De Santi; J Wegiel; H Wisniewski
Journal:  Psychiatr Q       Date:  1993

6.  Memory function in very early Alzheimer's disease.

Authors:  R C Petersen; G E Smith; R J Ivnik; E Kokmen; E G Tangalos
Journal:  Neurology       Date:  1994-05       Impact factor: 9.910

7.  Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease.

Authors:  R J Killiany; M B Moss; M S Albert; T Sandor; J Tieman; F Jolesz
Journal:  Arch Neurol       Date:  1993-09

8.  Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions.

Authors:  G W Rebeck; J S Reiter; D K Strickland; B T Hyman
Journal:  Neuron       Date:  1993-10       Impact factor: 17.173

Review 9.  Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype.

Authors:  W J Strittmatter; K H Weisgraber; M Goedert; A M Saunders; D Huang; E H Corder; L M Dong; R Jakes; M J Alberts; J R Gilbert
Journal:  Exp Neurol       Date:  1994-02       Impact factor: 5.330

10.  Apolipoprotein E: risk factor for Alzheimer disease.

Authors:  M S Tsai; E G Tangalos; R C Petersen; G E Smith; D J Schaid; E Kokmen; R J Ivnik; S N Thibodeau
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

View more
  54 in total

Review 1.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

2.  Age effects on atrophy rates of entorhinal cortex and hippocampus.

Authors:  An-Tao Du; Norbert Schuff; Linda L Chao; John Kornak; William J Jagust; Joel H Kramer; Bruce R Reed; Bruce L Miller; David Norman; Helena C Chui; Michael W Weiner
Journal:  Neurobiol Aging       Date:  2005-06-14       Impact factor: 4.673

3.  Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T.

Authors:  S G Mueller; N Schuff; S Raptentsetsang; J Elman; M W Weiner
Journal:  Neuroimage       Date:  2008-04-22       Impact factor: 6.556

4.  Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Authors:  David A Wolk; Bradford C Dickerson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 5.  Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease.

Authors:  Kejal Kantarci; Clifford R Jack
Journal:  NeuroRx       Date:  2004-04

6.  APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory.

Authors:  Geoffrey A Kerchner; Daniela Berdnik; Jadon C Shen; Jeffrey D Bernstein; Michelle C Fenesy; Gayle K Deutsch; Tony Wyss-Coray; Brian K Rutt
Journal:  Neurology       Date:  2014-01-22       Impact factor: 9.910

7.  Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment.

Authors:  Gloria C Chiang; Philip S Insel; Duygu Tosun; Norbert Schuff; Diana Truran-Sacrey; Sky T Raptentsetsang; Paul M Thompson; Eric M Reiman; Clifford R Jack; Nick C Fox; William J Jagust; Danielle J Harvey; Laurel A Beckett; Anthony Gamst; Paul S Aisen; Ron C Petersen; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

8.  Temporal lobe morphology in normal aging and traumatic brain injury.

Authors:  Erin D Bigler; Carol V Anderson; Duane D Blatter; Carol V Andersob
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

9.  Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

Authors:  Sean M Nestor; Raul Rupsingh; Michael Borrie; Matthew Smith; Vittorio Accomazzi; Jennie L Wells; Jennifer Fogarty; Robert Bartha
Journal:  Brain       Date:  2008-07-11       Impact factor: 13.501

10.  [Dementia-current knowledge and significance for ENT specialists].

Authors:  C Schwemmle; U Schwemmle; N Buller; M Ptok
Journal:  HNO       Date:  2004-12       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.